News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Philadelphia Ranks 4th Among National Life Sciences Markets in New Colliers Report
In the recently released Colliers 2024 Life Sciences Report, Philadelphia ranked #4 nationwide, with Boston, the San Francisco Bay Area and San Diego ranking first, second and third, respectively.
New Method Created for Improving the Resolution of Routine Medical Images
This novel method improves resolution of routine low resolution clinical images, saves MR scan time, and reduces radiation dosage levels for CT scanning.
Moderna Receives FDA Approval for RSV Vaccine Based on Penn Technology
RSV is a highly contagious seasonal respiratory virus and a leading cause of lower respiratory tract infections and pneumonia.
Penn Arts and Sciences’ MindCORE Neuroimaging Facility at Pennovation Works
The machine is the centerpiece of the new Neuroimaging Facility where scientists will study the mind-brain connection in-depth.
AI the Focus of Philly Tech Week Program hosted by PCI and PACT
PCI, along with Philadelphia Alliance for Capital and Technologies (PACT), hosted an AI-focused event called "AI Nexus: Shaping Tomorrow’s Intelligence."
Tech Talks: Bridging Academia and Innovation in Philadelphia’s Tech Hub
On April 24th, 2024, Penn hosted an event co-organized by the Mack Institute for Innovation Management and the City of Philadelphia Department of Commerce.
Penn Engineering Researchers Develop New Technology that Transforms Reflective Displays
The invention consists of an array of individually addressable microscale optical resonators and arrangements of optical components which allow a beam of light to circulate more efficiently.
PCI and Philadelphia Are Highlighted as Innovation Hubsat SXSW
The conference allowed PCI team members to meet a global network of investors and tech innovators.
2023 President’s Prize Winners: Where They Are Now?
The 2023 President’s Innovation Prize (PIP) and President’s Engagement Prize (PEP) winners have each made significant strides over the course of the past year.
LNP Research from the Mitchell Lab is Highlighted in the Philadelphia Inquirer
Mike Mitchell, PhD, was interviewed recently by the Philadelphia Inquirer about his cutting-edge research in lipid nanoparticles (LNPs), which are crucial for delivering mRNA into the body's cells.